Ark Invest has launched its first Defined Innovation Exposure Term (Diet) ETF, a new fund series designed to give investors exposure to disruptive technologies while reducing volatility

The Ark Diet Q4 Buffer ETF is now trading on the Cboe BZX Exchange. It is the first of four quarterly Diet ETFs that will roll out over the year, each offering a defined 12-month outcome period. ARK aims to give investors more flexibility in managing their innovation exposure The Diet structure is built on Ark’s flagship Ark Innovation ETF (ARKK) but adjusts the risk-return profile. Investors benefit from reduced downside, losses are roughly halved compared to ARKK’s decline over